nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PTGS2—colon cancer	0.17	0.54	CbGaD
Diclofenac—ABCB1—colon cancer	0.145	0.46	CbGaD
Diclofenac—SLCO1C1—Methotrexate—colon cancer	0.052	0.115	CbGbCtD
Diclofenac—UGT1A1—Irinotecan—colon cancer	0.0462	0.102	CbGbCtD
Diclofenac—ABCC4—Fluorouracil—colon cancer	0.0453	0.0998	CbGbCtD
Diclofenac—ABCC1—Irinotecan—colon cancer	0.0379	0.0836	CbGbCtD
Diclofenac—ABCC1—Vincristine—colon cancer	0.0332	0.073	CbGbCtD
Diclofenac—SLC22A11—Methotrexate—colon cancer	0.0268	0.0591	CbGbCtD
Diclofenac—ABCC4—Methotrexate—colon cancer	0.025	0.055	CbGbCtD
Diclofenac—ABCC1—Methotrexate—colon cancer	0.0201	0.0442	CbGbCtD
Diclofenac—CYP2B6—Irinotecan—colon cancer	0.0179	0.0393	CbGbCtD
Diclofenac—ALB—Irinotecan—colon cancer	0.0175	0.0385	CbGbCtD
Diclofenac—ALB—Fluorouracil—colon cancer	0.0168	0.037	CbGbCtD
Diclofenac—SLC22A8—Methotrexate—colon cancer	0.0156	0.0344	CbGbCtD
Diclofenac—CYP2C9—Capecitabine—colon cancer	0.0153	0.0336	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—colon cancer	0.013	0.0286	CbGbCtD
Diclofenac—SLC22A6—Methotrexate—colon cancer	0.0109	0.0239	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—colon cancer	0.01	0.0221	CbGbCtD
Diclofenac—ALB—Methotrexate—colon cancer	0.00926	0.0204	CbGbCtD
Diclofenac—ABCB1—Irinotecan—colon cancer	0.00915	0.0202	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—colon cancer	0.00905	0.0199	CbGbCtD
Diclofenac—ABCB1—Vincristine—colon cancer	0.008	0.0176	CbGbCtD
Diclofenac—CYP3A4—Irinotecan—colon cancer	0.00549	0.0121	CbGbCtD
Diclofenac—ABCB1—Methotrexate—colon cancer	0.00484	0.0107	CbGbCtD
Diclofenac—CYP3A4—Vincristine—colon cancer	0.00479	0.0106	CbGbCtD
Diclofenac—CXCR1—bone marrow—colon cancer	0.00222	0.042	CbGeAlD
Diclofenac—CXCR1—lymph node—colon cancer	0.00137	0.026	CbGeAlD
Diclofenac—PLA2G2A—epithelium—colon cancer	0.00113	0.0215	CbGeAlD
Diclofenac—PLA2G2A—smooth muscle tissue—colon cancer	0.00109	0.0207	CbGeAlD
Diclofenac—CXCL8—smooth muscle tissue—colon cancer	0.00108	0.0205	CbGeAlD
Diclofenac—ALB—gall bladder—colon cancer	0.00106	0.02	CbGeAlD
Diclofenac—PLA2G2A—renal system—colon cancer	0.00105	0.0199	CbGeAlD
Diclofenac—TTR—embryo—colon cancer	0.00105	0.0199	CbGeAlD
Diclofenac—SLCO1C1—renal system—colon cancer	0.000888	0.0168	CbGeAlD
Diclofenac—UGT2B7—renal system—colon cancer	0.000885	0.0168	CbGeAlD
Diclofenac—PLA2G2A—lymphoid tissue—colon cancer	0.000873	0.0165	CbGeAlD
Diclofenac—SLC22A11—renal system—colon cancer	0.000863	0.0163	CbGeAlD
Diclofenac—PLA2G2A—digestive system—colon cancer	0.000863	0.0163	CbGeAlD
Diclofenac—ASIC1—lymph node—colon cancer	0.000818	0.0155	CbGeAlD
Diclofenac—SCN4A—renal system—colon cancer	0.000816	0.0155	CbGeAlD
Diclofenac—TTR—renal system—colon cancer	0.000794	0.015	CbGeAlD
Diclofenac—CYP2C18—digestive system—colon cancer	0.000787	0.0149	CbGeAlD
Diclofenac—CXCL8—bone marrow—colon cancer	0.000787	0.0149	CbGeAlD
Diclofenac—CXCL8—vagina—colon cancer	0.000754	0.0143	CbGeAlD
Diclofenac—UGT1A1—renal system—colon cancer	0.000753	0.0143	CbGeAlD
Diclofenac—ALOX5—smooth muscle tissue—colon cancer	0.000747	0.0142	CbGeAlD
Diclofenac—UGT2B7—digestive system—colon cancer	0.000726	0.0138	CbGeAlD
Diclofenac—SLC22A11—digestive system—colon cancer	0.000708	0.0134	CbGeAlD
Diclofenac—CYP2C18—vagina—colon cancer	0.000695	0.0132	CbGeAlD
Diclofenac—PTGS1—endothelium—colon cancer	0.000694	0.0131	CbGeAlD
Diclofenac—Bromfenac—PTGS2—colon cancer	0.000683	0.232	CrCbGaD
Diclofenac—PTGS2—endothelium—colon cancer	0.000663	0.0126	CbGeAlD
Diclofenac—TTR—lymphoid tissue—colon cancer	0.000659	0.0125	CbGeAlD
Diclofenac—TTR—digestive system—colon cancer	0.000651	0.0123	CbGeAlD
Diclofenac—PLA2G2A—liver—colon cancer	0.000643	0.0122	CbGeAlD
Diclofenac—PTGS1—blood vessel—colon cancer	0.00064	0.0121	CbGeAlD
Diclofenac—CXCL8—liver—colon cancer	0.000636	0.0121	CbGeAlD
Diclofenac—UGT1A1—digestive system—colon cancer	0.000617	0.0117	CbGeAlD
Diclofenac—PTGS2—blood vessel—colon cancer	0.000611	0.0116	CbGeAlD
Diclofenac—TTR—bone marrow—colon cancer	0.0006	0.0114	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—colon cancer	0.000597	0.0113	CbGeAlD
Diclofenac—ALOX5—digestive system—colon cancer	0.00059	0.0112	CbGeAlD
Diclofenac—CYP2C18—liver—colon cancer	0.000587	0.0111	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—colon cancer	0.000581	0.198	CrCbGaD
Diclofenac—PTGS2—gall bladder—colon cancer	0.000575	0.0109	CbGeAlD
Diclofenac—Nepafenac—PTGS2—colon cancer	0.000553	0.188	CrCbGaD
Diclofenac—ALOX5—bone marrow—colon cancer	0.000544	0.0103	CbGeAlD
Diclofenac—UGT2B7—liver—colon cancer	0.000541	0.0102	CbGeAlD
Diclofenac—SLC22A11—liver—colon cancer	0.000527	0.00998	CbGeAlD
Diclofenac—PLA2G2A—lymph node—colon cancer	0.000493	0.00933	CbGeAlD
Diclofenac—ABCC4—renal system—colon cancer	0.000491	0.00929	CbGeAlD
Diclofenac—CXCL8—lymph node—colon cancer	0.000488	0.00924	CbGeAlD
Diclofenac—SLC22A8—renal system—colon cancer	0.000487	0.00922	CbGeAlD
Diclofenac—TTR—liver—colon cancer	0.000485	0.00919	CbGeAlD
Diclofenac—UGT1A1—liver—colon cancer	0.00046	0.00871	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—colon cancer	0.000453	0.154	CrCbGaD
Diclofenac—ALOX5—liver—colon cancer	0.00044	0.00833	CbGeAlD
Diclofenac—SLCO1C1—lymph node—colon cancer	0.000416	0.00788	CbGeAlD
Diclofenac—ABCC4—digestive system—colon cancer	0.000402	0.00762	CbGeAlD
Diclofenac—ABCB1—blood vessel—colon cancer	0.000378	0.00716	CbGeAlD
Diclofenac—ABCC4—bone marrow—colon cancer	0.000371	0.00703	CbGeAlD
Diclofenac—PTGS2—embryo—colon cancer	0.000365	0.00691	CbGeAlD
Diclofenac—CYP2C8—renal system—colon cancer	0.000356	0.00675	CbGeAlD
Diclofenac—CYP1A1—epithelium—colon cancer	0.000354	0.00671	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—colon cancer	0.000352	0.12	CrCbGaD
Diclofenac—ALOX5—lymph node—colon cancer	0.000337	0.00638	CbGeAlD
Diclofenac—CYP2C19—digestive system—colon cancer	0.000335	0.00634	CbGeAlD
Diclofenac—CYP1A2—renal system—colon cancer	0.000333	0.00631	CbGeAlD
Diclofenac—CYP1A1—renal system—colon cancer	0.000329	0.00623	CbGeAlD
Diclofenac—CYP2B6—renal system—colon cancer	0.000319	0.00605	CbGeAlD
Diclofenac—Clonidine—ABCB1—colon cancer	0.000318	0.108	CrCbGaD
Diclofenac—PTGS1—epithelium—colon cancer	0.000311	0.0059	CbGeAlD
Diclofenac—ALB—liver—colon cancer	0.00031	0.00587	CbGeAlD
Diclofenac—ABCC1—vagina—colon cancer	0.000303	0.00574	CbGeAlD
Diclofenac—PTGS1—smooth muscle tissue—colon cancer	0.0003	0.00568	CbGeAlD
Diclofenac—CYP2E1—renal system—colon cancer	0.0003	0.00568	CbGeAlD
Diclofenac—ABCC4—liver—colon cancer	0.0003	0.00568	CbGeAlD
Diclofenac—PTGS2—epithelium—colon cancer	0.000298	0.00564	CbGeAlD
Diclofenac—CYP2C19—vagina—colon cancer	0.000296	0.0056	CbGeAlD
Diclofenac—PTGS1—renal system—colon cancer	0.000289	0.00547	CbGeAlD
Diclofenac—PTGS2—smooth muscle tissue—colon cancer	0.000287	0.00543	CbGeAlD
Diclofenac—PTGS2—renal system—colon cancer	0.000276	0.00523	CbGeAlD
Diclofenac—CYP1A2—digestive system—colon cancer	0.000273	0.00518	CbGeAlD
Diclofenac—CYP1A1—digestive system—colon cancer	0.00027	0.00511	CbGeAlD
Diclofenac—CYP2B6—lymphoid tissue—colon cancer	0.000265	0.00502	CbGeAlD
Diclofenac—CYP2B6—digestive system—colon cancer	0.000262	0.00496	CbGeAlD
Diclofenac—CYP2C9—digestive system—colon cancer	0.000259	0.00491	CbGeAlD
Diclofenac—CYP2C8—vagina—colon cancer	0.000258	0.00489	CbGeAlD
Diclofenac—ABCC1—liver—colon cancer	0.000256	0.00484	CbGeAlD
Diclofenac—CYP2C19—liver—colon cancer	0.000249	0.00472	CbGeAlD
Diclofenac—CYP2E1—lymphoid tissue—colon cancer	0.000249	0.00472	CbGeAlD
Diclofenac—CYP2E1—digestive system—colon cancer	0.000246	0.00466	CbGeAlD
Diclofenac—CYP3A4—renal system—colon cancer	0.000241	0.00457	CbGeAlD
Diclofenac—CYP1A1—vagina—colon cancer	0.000238	0.00451	CbGeAlD
Diclofenac—ALB—lymph node—colon cancer	0.000237	0.0045	CbGeAlD
Diclofenac—PTGS1—digestive system—colon cancer	0.000237	0.00449	CbGeAlD
Diclofenac—CYP2B6—vagina—colon cancer	0.000231	0.00438	CbGeAlD
Diclofenac—ABCC4—lymph node—colon cancer	0.00023	0.00435	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—colon cancer	0.000229	0.00434	CbGeAlD
Diclofenac—PTGS2—digestive system—colon cancer	0.000226	0.00429	CbGeAlD
Diclofenac—ABCB1—embryo—colon cancer	0.000226	0.00427	CbGeAlD
Diclofenac—CYP2C8—liver—colon cancer	0.000218	0.00412	CbGeAlD
Diclofenac—PTGS1—vagina—colon cancer	0.000209	0.00396	CbGeAlD
Diclofenac—PTGS2—bone marrow—colon cancer	0.000209	0.00395	CbGeAlD
Diclofenac—CYP1A2—liver—colon cancer	0.000204	0.00386	CbGeAlD
Diclofenac—CYP1A1—liver—colon cancer	0.000201	0.0038	CbGeAlD
Diclofenac—PTGS2—vagina—colon cancer	0.0002	0.00379	CbGeAlD
Diclofenac—CYP3A4—digestive system—colon cancer	0.000198	0.00375	CbGeAlD
Diclofenac—ABCC1—lymph node—colon cancer	0.000196	0.00371	CbGeAlD
Diclofenac—CYP2B6—liver—colon cancer	0.000195	0.0037	CbGeAlD
Diclofenac—CYP2C9—liver—colon cancer	0.000193	0.00366	CbGeAlD
Diclofenac—ABCB1—epithelium—colon cancer	0.000184	0.00349	CbGeAlD
Diclofenac—CYP2E1—liver—colon cancer	0.000183	0.00347	CbGeAlD
Diclofenac—ABCB1—renal system—colon cancer	0.000171	0.00323	CbGeAlD
Diclofenac—PTGS2—liver—colon cancer	0.000169	0.0032	CbGeAlD
Diclofenac—CYP1A1—lymph node—colon cancer	0.000154	0.00292	CbGeAlD
Diclofenac—CYP3A4—liver—colon cancer	0.000147	0.00279	CbGeAlD
Diclofenac—ABCB1—lymphoid tissue—colon cancer	0.000142	0.00269	CbGeAlD
Diclofenac—ABCB1—digestive system—colon cancer	0.00014	0.00265	CbGeAlD
Diclofenac—PTGS1—lymph node—colon cancer	0.000135	0.00256	CbGeAlD
Diclofenac—Bradycardia—Capecitabine—colon cancer	0.000131	0.00104	CcSEcCtD
Diclofenac—Oedema—Fluorouracil—colon cancer	0.00013	0.00104	CcSEcCtD
Diclofenac—Anaphylactic shock—Fluorouracil—colon cancer	0.00013	0.00104	CcSEcCtD
Diclofenac—Anorexia—Irinotecan—colon cancer	0.00013	0.00103	CcSEcCtD
Diclofenac—Infection—Fluorouracil—colon cancer	0.00013	0.00103	CcSEcCtD
Diclofenac—PTGS2—lymph node—colon cancer	0.000129	0.00245	CbGeAlD
Diclofenac—ABCB1—bone marrow—colon cancer	0.000129	0.00245	CbGeAlD
Diclofenac—Haemoglobin—Capecitabine—colon cancer	0.000129	0.00103	CcSEcCtD
Diclofenac—Rhinitis—Capecitabine—colon cancer	0.000129	0.00102	CcSEcCtD
Diclofenac—Hepatitis—Capecitabine—colon cancer	0.000128	0.00102	CcSEcCtD
Diclofenac—Haemorrhage—Capecitabine—colon cancer	0.000128	0.00102	CcSEcCtD
Diclofenac—Nervous system disorder—Fluorouracil—colon cancer	0.000128	0.00102	CcSEcCtD
Diclofenac—Thrombocytopenia—Fluorouracil—colon cancer	0.000128	0.00102	CcSEcCtD
Diclofenac—Hypoaesthesia—Capecitabine—colon cancer	0.000128	0.00102	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Vincristine—colon cancer	0.000127	0.00101	CcSEcCtD
Diclofenac—Pharyngitis—Capecitabine—colon cancer	0.000127	0.00101	CcSEcCtD
Diclofenac—Tachycardia—Fluorouracil—colon cancer	0.000127	0.00101	CcSEcCtD
Diclofenac—Hypotension—Irinotecan—colon cancer	0.000127	0.00101	CcSEcCtD
Diclofenac—Urinary tract disorder—Capecitabine—colon cancer	0.000127	0.00101	CcSEcCtD
Diclofenac—Insomnia—Vincristine—colon cancer	0.000126	0.00101	CcSEcCtD
Diclofenac—Oedema peripheral—Capecitabine—colon cancer	0.000126	0.00101	CcSEcCtD
Diclofenac—Urethral disorder—Capecitabine—colon cancer	0.000126	0.001	CcSEcCtD
Diclofenac—Paraesthesia—Vincristine—colon cancer	0.000126	0.001	CcSEcCtD
Diclofenac—Anorexia—Fluorouracil—colon cancer	0.000124	0.00099	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000124	0.00099	CcSEcCtD
Diclofenac—ABCB1—vagina—colon cancer	0.000124	0.00234	CbGeAlD
Diclofenac—Visual impairment—Capecitabine—colon cancer	0.000124	0.000984	CcSEcCtD
Diclofenac—Insomnia—Irinotecan—colon cancer	0.000123	0.000981	CcSEcCtD
Diclofenac—Paraesthesia—Irinotecan—colon cancer	0.000122	0.000973	CcSEcCtD
Diclofenac—Hypotension—Fluorouracil—colon cancer	0.000122	0.00097	CcSEcCtD
Diclofenac—Decreased appetite—Vincristine—colon cancer	0.000122	0.000968	CcSEcCtD
Diclofenac—Dyspnoea—Irinotecan—colon cancer	0.000121	0.000966	CcSEcCtD
Diclofenac—Erythema multiforme—Capecitabine—colon cancer	0.000121	0.000966	CcSEcCtD
Diclofenac—Somnolence—Irinotecan—colon cancer	0.000121	0.000964	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Vincristine—colon cancer	0.000121	0.000961	CcSEcCtD
Diclofenac—Fatigue—Vincristine—colon cancer	0.000121	0.00096	CcSEcCtD
Diclofenac—Eye disorder—Capecitabine—colon cancer	0.00012	0.000954	CcSEcCtD
Diclofenac—Dyspepsia—Irinotecan—colon cancer	0.00012	0.000954	CcSEcCtD
Diclofenac—Tinnitus—Capecitabine—colon cancer	0.00012	0.000952	CcSEcCtD
Diclofenac—Pain—Vincristine—colon cancer	0.00012	0.000952	CcSEcCtD
Diclofenac—Constipation—Vincristine—colon cancer	0.00012	0.000952	CcSEcCtD
Diclofenac—Asthma—Methotrexate—colon cancer	0.000119	0.00095	CcSEcCtD
Diclofenac—Flushing—Capecitabine—colon cancer	0.000119	0.000948	CcSEcCtD
Diclofenac—Cardiac disorder—Capecitabine—colon cancer	0.000119	0.000948	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000119	0.000946	CcSEcCtD
Diclofenac—Decreased appetite—Irinotecan—colon cancer	0.000118	0.000942	CcSEcCtD
Diclofenac—Eosinophilia—Methotrexate—colon cancer	0.000118	0.00094	CcSEcCtD
Diclofenac—Insomnia—Fluorouracil—colon cancer	0.000118	0.000939	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Irinotecan—colon cancer	0.000118	0.000936	CcSEcCtD
Diclofenac—Fatigue—Irinotecan—colon cancer	0.000117	0.000935	CcSEcCtD
Diclofenac—Paraesthesia—Fluorouracil—colon cancer	0.000117	0.000932	CcSEcCtD
Diclofenac—Pancreatitis—Methotrexate—colon cancer	0.000117	0.000931	CcSEcCtD
Diclofenac—Pain—Irinotecan—colon cancer	0.000116	0.000927	CcSEcCtD
Diclofenac—Constipation—Irinotecan—colon cancer	0.000116	0.000927	CcSEcCtD
Diclofenac—Angiopathy—Capecitabine—colon cancer	0.000116	0.000927	CcSEcCtD
Diclofenac—Dyspnoea—Fluorouracil—colon cancer	0.000116	0.000926	CcSEcCtD
Diclofenac—Somnolence—Fluorouracil—colon cancer	0.000116	0.000923	CcSEcCtD
Diclofenac—Immune system disorder—Capecitabine—colon cancer	0.000116	0.000922	CcSEcCtD
Diclofenac—Mediastinal disorder—Capecitabine—colon cancer	0.000116	0.00092	CcSEcCtD
Diclofenac—Chills—Capecitabine—colon cancer	0.000115	0.000916	CcSEcCtD
Diclofenac—Dyspepsia—Fluorouracil—colon cancer	0.000115	0.000914	CcSEcCtD
Diclofenac—Arrhythmia—Capecitabine—colon cancer	0.000115	0.000912	CcSEcCtD
Diclofenac—Abdominal discomfort—Methotrexate—colon cancer	0.000114	0.000911	CcSEcCtD
Diclofenac—Gastrointestinal pain—Vincristine—colon cancer	0.000114	0.00091	CcSEcCtD
Diclofenac—Decreased appetite—Fluorouracil—colon cancer	0.000113	0.000903	CcSEcCtD
Diclofenac—Alopecia—Capecitabine—colon cancer	0.000113	0.000902	CcSEcCtD
Diclofenac—Pancytopenia—Methotrexate—colon cancer	0.000113	0.000902	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000113	0.000896	CcSEcCtD
Diclofenac—Mental disorder—Capecitabine—colon cancer	0.000112	0.000895	CcSEcCtD
Diclofenac—Feeling abnormal—Irinotecan—colon cancer	0.000112	0.000893	CcSEcCtD
Diclofenac—Erythema—Capecitabine—colon cancer	0.000112	0.000889	CcSEcCtD
Diclofenac—Malnutrition—Capecitabine—colon cancer	0.000112	0.000889	CcSEcCtD
Diclofenac—Dysuria—Methotrexate—colon cancer	0.000112	0.000888	CcSEcCtD
Diclofenac—Pain—Fluorouracil—colon cancer	0.000111	0.000888	CcSEcCtD
Diclofenac—Gastrointestinal pain—Irinotecan—colon cancer	0.000111	0.000886	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Methotrexate—colon cancer	0.000111	0.000883	CcSEcCtD
Diclofenac—Abdominal pain—Vincristine—colon cancer	0.000111	0.00088	CcSEcCtD
Diclofenac—Body temperature increased—Vincristine—colon cancer	0.000111	0.00088	CcSEcCtD
Diclofenac—Flatulence—Capecitabine—colon cancer	0.00011	0.000876	CcSEcCtD
Diclofenac—Erectile dysfunction—Methotrexate—colon cancer	0.00011	0.000875	CcSEcCtD
Diclofenac—Dysgeusia—Capecitabine—colon cancer	0.000109	0.000871	CcSEcCtD
Diclofenac—Photosensitivity reaction—Methotrexate—colon cancer	0.000109	0.000867	CcSEcCtD
Diclofenac—Back pain—Capecitabine—colon cancer	0.000108	0.00086	CcSEcCtD
Diclofenac—Abdominal pain—Irinotecan—colon cancer	0.000108	0.000857	CcSEcCtD
Diclofenac—Body temperature increased—Irinotecan—colon cancer	0.000108	0.000857	CcSEcCtD
Diclofenac—Feeling abnormal—Fluorouracil—colon cancer	0.000107	0.000856	CcSEcCtD
Diclofenac—Muscle spasms—Capecitabine—colon cancer	0.000107	0.000855	CcSEcCtD
Diclofenac—Pneumonia—Methotrexate—colon cancer	0.000107	0.000852	CcSEcCtD
Diclofenac—Infestation—Methotrexate—colon cancer	0.000106	0.000847	CcSEcCtD
Diclofenac—Drowsiness—Methotrexate—colon cancer	0.000106	0.000847	CcSEcCtD
Diclofenac—Infestation NOS—Methotrexate—colon cancer	0.000106	0.000847	CcSEcCtD
Diclofenac—Depression—Methotrexate—colon cancer	0.000106	0.000844	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000105	0.00084	CcSEcCtD
Diclofenac—Vision blurred—Capecitabine—colon cancer	0.000105	0.000838	CcSEcCtD
Diclofenac—Tremor—Capecitabine—colon cancer	0.000105	0.000833	CcSEcCtD
Diclofenac—Renal failure—Methotrexate—colon cancer	0.000105	0.000832	CcSEcCtD
Diclofenac—ABCB1—liver—colon cancer	0.000104	0.00198	CbGeAlD
Diclofenac—Stomatitis—Methotrexate—colon cancer	0.000104	0.000825	CcSEcCtD
Diclofenac—Ill-defined disorder—Capecitabine—colon cancer	0.000104	0.000825	CcSEcCtD
Diclofenac—Urticaria—Fluorouracil—colon cancer	0.000104	0.000825	CcSEcCtD
Diclofenac—Conjunctivitis—Methotrexate—colon cancer	0.000103	0.000823	CcSEcCtD
Diclofenac—Anaemia—Capecitabine—colon cancer	0.000103	0.000822	CcSEcCtD
Diclofenac—Body temperature increased—Fluorouracil—colon cancer	0.000103	0.000821	CcSEcCtD
Diclofenac—Hypersensitivity—Vincristine—colon cancer	0.000103	0.00082	CcSEcCtD
Diclofenac—Sweating—Methotrexate—colon cancer	0.000102	0.000812	CcSEcCtD
Diclofenac—Haematuria—Methotrexate—colon cancer	0.000101	0.000807	CcSEcCtD
Diclofenac—Malaise—Capecitabine—colon cancer	0.000101	0.000802	CcSEcCtD
Diclofenac—Hepatobiliary disease—Methotrexate—colon cancer	0.000101	0.000801	CcSEcCtD
Diclofenac—Epistaxis—Methotrexate—colon cancer	0.0001	0.000799	CcSEcCtD
Diclofenac—Vertigo—Capecitabine—colon cancer	0.0001	0.000799	CcSEcCtD
Diclofenac—Hypersensitivity—Irinotecan—colon cancer	0.0001	0.000799	CcSEcCtD
Diclofenac—Asthenia—Vincristine—colon cancer	0.0001	0.000799	CcSEcCtD
Diclofenac—Syncope—Capecitabine—colon cancer	0.0001	0.000797	CcSEcCtD
Diclofenac—Leukopenia—Capecitabine—colon cancer	9.99e-05	0.000796	CcSEcCtD
Diclofenac—Agranulocytosis—Methotrexate—colon cancer	9.92e-05	0.00079	CcSEcCtD
Diclofenac—Palpitations—Capecitabine—colon cancer	9.87e-05	0.000786	CcSEcCtD
Diclofenac—Loss of consciousness—Capecitabine—colon cancer	9.81e-05	0.000781	CcSEcCtD
Diclofenac—Asthenia—Irinotecan—colon cancer	9.77e-05	0.000778	CcSEcCtD
Diclofenac—Cough—Capecitabine—colon cancer	9.74e-05	0.000776	CcSEcCtD
Diclofenac—Hypertension—Capecitabine—colon cancer	9.64e-05	0.000768	CcSEcCtD
Diclofenac—Hypersensitivity—Fluorouracil—colon cancer	9.61e-05	0.000765	CcSEcCtD
Diclofenac—Haemoglobin—Methotrexate—colon cancer	9.6e-05	0.000764	CcSEcCtD
Diclofenac—Diarrhoea—Vincristine—colon cancer	9.56e-05	0.000762	CcSEcCtD
Diclofenac—Hepatitis—Methotrexate—colon cancer	9.55e-05	0.00076	CcSEcCtD
Diclofenac—Haemorrhage—Methotrexate—colon cancer	9.55e-05	0.00076	CcSEcCtD
Diclofenac—Chest pain—Capecitabine—colon cancer	9.5e-05	0.000757	CcSEcCtD
Diclofenac—Myalgia—Capecitabine—colon cancer	9.5e-05	0.000757	CcSEcCtD
Diclofenac—Arthralgia—Capecitabine—colon cancer	9.5e-05	0.000757	CcSEcCtD
Diclofenac—Pharyngitis—Methotrexate—colon cancer	9.48e-05	0.000755	CcSEcCtD
Diclofenac—Anxiety—Capecitabine—colon cancer	9.47e-05	0.000754	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	9.44e-05	0.000752	CcSEcCtD
Diclofenac—Urinary tract disorder—Methotrexate—colon cancer	9.43e-05	0.000751	CcSEcCtD
Diclofenac—Discomfort—Capecitabine—colon cancer	9.39e-05	0.000748	CcSEcCtD
Diclofenac—Urethral disorder—Methotrexate—colon cancer	9.36e-05	0.000745	CcSEcCtD
Diclofenac—Diarrhoea—Irinotecan—colon cancer	9.31e-05	0.000742	CcSEcCtD
Diclofenac—Dry mouth—Capecitabine—colon cancer	9.3e-05	0.00074	CcSEcCtD
Diclofenac—Dizziness—Vincristine—colon cancer	9.24e-05	0.000736	CcSEcCtD
Diclofenac—Pruritus—Fluorouracil—colon cancer	9.22e-05	0.000735	CcSEcCtD
Diclofenac—Visual impairment—Methotrexate—colon cancer	9.2e-05	0.000733	CcSEcCtD
Diclofenac—Confusional state—Capecitabine—colon cancer	9.19e-05	0.000732	CcSEcCtD
Diclofenac—Oedema—Capecitabine—colon cancer	9.11e-05	0.000726	CcSEcCtD
Diclofenac—Infection—Capecitabine—colon cancer	9.05e-05	0.000721	CcSEcCtD
Diclofenac—Erythema multiforme—Methotrexate—colon cancer	9.03e-05	0.000719	CcSEcCtD
Diclofenac—Dizziness—Irinotecan—colon cancer	9e-05	0.000717	CcSEcCtD
Diclofenac—Shock—Capecitabine—colon cancer	8.96e-05	0.000714	CcSEcCtD
Diclofenac—Nervous system disorder—Capecitabine—colon cancer	8.94e-05	0.000712	CcSEcCtD
Diclofenac—Eye disorder—Methotrexate—colon cancer	8.92e-05	0.00071	CcSEcCtD
Diclofenac—Diarrhoea—Fluorouracil—colon cancer	8.92e-05	0.00071	CcSEcCtD
Diclofenac—Thrombocytopenia—Capecitabine—colon cancer	8.92e-05	0.00071	CcSEcCtD
Diclofenac—Tinnitus—Methotrexate—colon cancer	8.9e-05	0.000709	CcSEcCtD
Diclofenac—Tachycardia—Capecitabine—colon cancer	8.89e-05	0.000708	CcSEcCtD
Diclofenac—Vomiting—Vincristine—colon cancer	8.89e-05	0.000708	CcSEcCtD
Diclofenac—Cardiac disorder—Methotrexate—colon cancer	8.86e-05	0.000706	CcSEcCtD
Diclofenac—Skin disorder—Capecitabine—colon cancer	8.85e-05	0.000705	CcSEcCtD
Diclofenac—Rash—Vincristine—colon cancer	8.81e-05	0.000702	CcSEcCtD
Diclofenac—Hyperhidrosis—Capecitabine—colon cancer	8.81e-05	0.000701	CcSEcCtD
Diclofenac—Dermatitis—Vincristine—colon cancer	8.81e-05	0.000701	CcSEcCtD
Diclofenac—Headache—Vincristine—colon cancer	8.76e-05	0.000697	CcSEcCtD
Diclofenac—Anorexia—Capecitabine—colon cancer	8.69e-05	0.000692	CcSEcCtD
Diclofenac—Angiopathy—Methotrexate—colon cancer	8.66e-05	0.00069	CcSEcCtD
Diclofenac—Vomiting—Irinotecan—colon cancer	8.66e-05	0.000689	CcSEcCtD
Diclofenac—Immune system disorder—Methotrexate—colon cancer	8.62e-05	0.000687	CcSEcCtD
Diclofenac—Dizziness—Fluorouracil—colon cancer	8.62e-05	0.000687	CcSEcCtD
Diclofenac—Mediastinal disorder—Methotrexate—colon cancer	8.6e-05	0.000685	CcSEcCtD
Diclofenac—Rash—Irinotecan—colon cancer	8.58e-05	0.000684	CcSEcCtD
Diclofenac—Dermatitis—Irinotecan—colon cancer	8.58e-05	0.000683	CcSEcCtD
Diclofenac—Chills—Methotrexate—colon cancer	8.57e-05	0.000682	CcSEcCtD
Diclofenac—Headache—Irinotecan—colon cancer	8.53e-05	0.000679	CcSEcCtD
Diclofenac—Hypotension—Capecitabine—colon cancer	8.51e-05	0.000678	CcSEcCtD
Diclofenac—Alopecia—Methotrexate—colon cancer	8.44e-05	0.000672	CcSEcCtD
Diclofenac—Mental disorder—Methotrexate—colon cancer	8.36e-05	0.000666	CcSEcCtD
Diclofenac—Erythema—Methotrexate—colon cancer	8.31e-05	0.000662	CcSEcCtD
Diclofenac—Malnutrition—Methotrexate—colon cancer	8.31e-05	0.000662	CcSEcCtD
Diclofenac—Nausea—Vincristine—colon cancer	8.3e-05	0.000661	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Capecitabine—colon cancer	8.3e-05	0.000661	CcSEcCtD
Diclofenac—Vomiting—Fluorouracil—colon cancer	8.29e-05	0.00066	CcSEcCtD
Diclofenac—Insomnia—Capecitabine—colon cancer	8.24e-05	0.000656	CcSEcCtD
Diclofenac—Rash—Fluorouracil—colon cancer	8.22e-05	0.000655	CcSEcCtD
Diclofenac—Dermatitis—Fluorouracil—colon cancer	8.21e-05	0.000654	CcSEcCtD
Diclofenac—Paraesthesia—Capecitabine—colon cancer	8.18e-05	0.000652	CcSEcCtD
Diclofenac—Headache—Fluorouracil—colon cancer	8.17e-05	0.00065	CcSEcCtD
Diclofenac—Dysgeusia—Methotrexate—colon cancer	8.14e-05	0.000648	CcSEcCtD
Diclofenac—Dyspnoea—Capecitabine—colon cancer	8.12e-05	0.000647	CcSEcCtD
Diclofenac—Nausea—Irinotecan—colon cancer	8.09e-05	0.000644	CcSEcCtD
Diclofenac—Back pain—Methotrexate—colon cancer	8.04e-05	0.00064	CcSEcCtD
Diclofenac—Dyspepsia—Capecitabine—colon cancer	8.02e-05	0.000639	CcSEcCtD
Diclofenac—ABCB1—lymph node—colon cancer	8e-05	0.00152	CbGeAlD
Diclofenac—Decreased appetite—Capecitabine—colon cancer	7.92e-05	0.000631	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Capecitabine—colon cancer	7.87e-05	0.000626	CcSEcCtD
Diclofenac—Fatigue—Capecitabine—colon cancer	7.86e-05	0.000626	CcSEcCtD
Diclofenac—Vision blurred—Methotrexate—colon cancer	7.83e-05	0.000624	CcSEcCtD
Diclofenac—Pain—Capecitabine—colon cancer	7.79e-05	0.00062	CcSEcCtD
Diclofenac—Constipation—Capecitabine—colon cancer	7.79e-05	0.00062	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—colon cancer	7.74e-05	0.000617	CcSEcCtD
Diclofenac—Ill-defined disorder—Methotrexate—colon cancer	7.71e-05	0.000614	CcSEcCtD
Diclofenac—Anaemia—Methotrexate—colon cancer	7.68e-05	0.000612	CcSEcCtD
Diclofenac—Feeling abnormal—Capecitabine—colon cancer	7.51e-05	0.000598	CcSEcCtD
Diclofenac—Malaise—Methotrexate—colon cancer	7.49e-05	0.000597	CcSEcCtD
Diclofenac—Vertigo—Methotrexate—colon cancer	7.47e-05	0.000595	CcSEcCtD
Diclofenac—Gastrointestinal pain—Capecitabine—colon cancer	7.45e-05	0.000593	CcSEcCtD
Diclofenac—Leukopenia—Methotrexate—colon cancer	7.44e-05	0.000592	CcSEcCtD
Diclofenac—Cough—Methotrexate—colon cancer	7.25e-05	0.000578	CcSEcCtD
Diclofenac—Urticaria—Capecitabine—colon cancer	7.24e-05	0.000576	CcSEcCtD
Diclofenac—Abdominal pain—Capecitabine—colon cancer	7.2e-05	0.000574	CcSEcCtD
Diclofenac—Body temperature increased—Capecitabine—colon cancer	7.2e-05	0.000574	CcSEcCtD
Diclofenac—Convulsion—Methotrexate—colon cancer	7.2e-05	0.000573	CcSEcCtD
Diclofenac—Arthralgia—Methotrexate—colon cancer	7.08e-05	0.000563	CcSEcCtD
Diclofenac—Chest pain—Methotrexate—colon cancer	7.08e-05	0.000563	CcSEcCtD
Diclofenac—Myalgia—Methotrexate—colon cancer	7.08e-05	0.000563	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	7.03e-05	0.00056	CcSEcCtD
Diclofenac—Discomfort—Methotrexate—colon cancer	6.99e-05	0.000557	CcSEcCtD
Diclofenac—Confusional state—Methotrexate—colon cancer	6.84e-05	0.000545	CcSEcCtD
Diclofenac—Anaphylactic shock—Methotrexate—colon cancer	6.78e-05	0.00054	CcSEcCtD
Diclofenac—Infection—Methotrexate—colon cancer	6.74e-05	0.000537	CcSEcCtD
Diclofenac—Hypersensitivity—Capecitabine—colon cancer	6.71e-05	0.000535	CcSEcCtD
Diclofenac—Nervous system disorder—Methotrexate—colon cancer	6.65e-05	0.00053	CcSEcCtD
Diclofenac—Thrombocytopenia—Methotrexate—colon cancer	6.64e-05	0.000529	CcSEcCtD
Diclofenac—Skin disorder—Methotrexate—colon cancer	6.59e-05	0.000525	CcSEcCtD
Diclofenac—Hyperhidrosis—Methotrexate—colon cancer	6.56e-05	0.000522	CcSEcCtD
Diclofenac—Asthenia—Capecitabine—colon cancer	6.54e-05	0.000521	CcSEcCtD
Diclofenac—Anorexia—Methotrexate—colon cancer	6.47e-05	0.000515	CcSEcCtD
Diclofenac—Pruritus—Capecitabine—colon cancer	6.45e-05	0.000513	CcSEcCtD
Diclofenac—Hypotension—Methotrexate—colon cancer	6.34e-05	0.000505	CcSEcCtD
Diclofenac—Diarrhoea—Capecitabine—colon cancer	6.23e-05	0.000496	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Methotrexate—colon cancer	6.18e-05	0.000492	CcSEcCtD
Diclofenac—Insomnia—Methotrexate—colon cancer	6.13e-05	0.000489	CcSEcCtD
Diclofenac—Paraesthesia—Methotrexate—colon cancer	6.09e-05	0.000485	CcSEcCtD
Diclofenac—Dyspnoea—Methotrexate—colon cancer	6.05e-05	0.000482	CcSEcCtD
Diclofenac—Somnolence—Methotrexate—colon cancer	6.03e-05	0.00048	CcSEcCtD
Diclofenac—Dizziness—Capecitabine—colon cancer	6.03e-05	0.00048	CcSEcCtD
Diclofenac—Dyspepsia—Methotrexate—colon cancer	5.97e-05	0.000475	CcSEcCtD
Diclofenac—Decreased appetite—Methotrexate—colon cancer	5.9e-05	0.00047	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Methotrexate—colon cancer	5.86e-05	0.000466	CcSEcCtD
Diclofenac—Fatigue—Methotrexate—colon cancer	5.85e-05	0.000466	CcSEcCtD
Diclofenac—Pain—Methotrexate—colon cancer	5.8e-05	0.000462	CcSEcCtD
Diclofenac—Vomiting—Capecitabine—colon cancer	5.79e-05	0.000461	CcSEcCtD
Diclofenac—Rash—Capecitabine—colon cancer	5.74e-05	0.000457	CcSEcCtD
Diclofenac—Dermatitis—Capecitabine—colon cancer	5.74e-05	0.000457	CcSEcCtD
Diclofenac—Headache—Capecitabine—colon cancer	5.71e-05	0.000455	CcSEcCtD
Diclofenac—Feeling abnormal—Methotrexate—colon cancer	5.59e-05	0.000445	CcSEcCtD
Diclofenac—Gastrointestinal pain—Methotrexate—colon cancer	5.55e-05	0.000442	CcSEcCtD
Diclofenac—Nausea—Capecitabine—colon cancer	5.41e-05	0.000431	CcSEcCtD
Diclofenac—Urticaria—Methotrexate—colon cancer	5.39e-05	0.000429	CcSEcCtD
Diclofenac—Abdominal pain—Methotrexate—colon cancer	5.36e-05	0.000427	CcSEcCtD
Diclofenac—Body temperature increased—Methotrexate—colon cancer	5.36e-05	0.000427	CcSEcCtD
Diclofenac—Hypersensitivity—Methotrexate—colon cancer	5e-05	0.000398	CcSEcCtD
Diclofenac—Asthenia—Methotrexate—colon cancer	4.87e-05	0.000388	CcSEcCtD
Diclofenac—Pruritus—Methotrexate—colon cancer	4.8e-05	0.000382	CcSEcCtD
Diclofenac—Diarrhoea—Methotrexate—colon cancer	4.64e-05	0.00037	CcSEcCtD
Diclofenac—Dizziness—Methotrexate—colon cancer	4.49e-05	0.000357	CcSEcCtD
Diclofenac—Vomiting—Methotrexate—colon cancer	4.31e-05	0.000343	CcSEcCtD
Diclofenac—Rash—Methotrexate—colon cancer	4.28e-05	0.000341	CcSEcCtD
Diclofenac—Dermatitis—Methotrexate—colon cancer	4.27e-05	0.00034	CcSEcCtD
Diclofenac—Headache—Methotrexate—colon cancer	4.25e-05	0.000338	CcSEcCtD
Diclofenac—Nausea—Methotrexate—colon cancer	4.03e-05	0.000321	CcSEcCtD
Diclofenac—CXCR1—Signaling Pathways—KRAS—colon cancer	1.16e-05	0.000235	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.16e-05	0.000235	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ABCB1—colon cancer	1.16e-05	0.000235	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.15e-05	0.000233	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.14e-05	0.000231	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—TYMS—colon cancer	1.14e-05	0.00023	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.14e-05	0.00023	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.13e-05	0.000229	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FGFR3—colon cancer	1.13e-05	0.000228	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ABCB1—colon cancer	1.12e-05	0.000226	CbGpPWpGaD
Diclofenac—TTR—Disease—KRAS—colon cancer	1.12e-05	0.000226	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—PIK3CA—colon cancer	1.12e-05	0.000226	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.11e-05	0.000225	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.11e-05	0.000225	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—TYMS—colon cancer	1.1e-05	0.000222	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CASP3—colon cancer	1.09e-05	0.00022	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—colon cancer	1.08e-05	0.000218	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—PIK3CA—colon cancer	1.07e-05	0.000216	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCND1—colon cancer	1.06e-05	0.000214	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.05e-05	0.000212	CbGpPWpGaD
Diclofenac—ABCC1—Disease—FGFR3—colon cancer	1.05e-05	0.000212	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CTNNB1—colon cancer	1.05e-05	0.000212	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.04e-05	0.000211	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—colon cancer	1.04e-05	0.000209	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—APC—colon cancer	1.03e-05	0.000209	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—colon cancer	1.03e-05	0.000209	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—colon cancer	1.03e-05	0.000209	CbGpPWpGaD
Diclofenac—TTR—Disease—PIK3CA—colon cancer	1.03e-05	0.000208	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CDKN1A—colon cancer	1.02e-05	0.000207	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PPARG—colon cancer	1.02e-05	0.000207	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PIK3CA—colon cancer	1e-05	0.000202	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PPARG—colon cancer	9.94e-06	0.000201	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—EP300—colon cancer	9.94e-06	0.000201	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—colon cancer	9.9e-06	0.0002	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	9.79e-06	0.000198	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EP300—colon cancer	9.73e-06	0.000197	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—BRAF—colon cancer	9.72e-06	0.000196	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.67e-06	0.000196	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	9.64e-06	0.000195	CbGpPWpGaD
Diclofenac—ABCC1—Disease—APC—colon cancer	9.64e-06	0.000195	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.55e-06	0.000193	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—colon cancer	9.51e-06	0.000192	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.5e-06	0.000192	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SRC—colon cancer	9.47e-06	0.000191	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ABCB1—colon cancer	9.47e-06	0.000191	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—colon cancer	9.42e-06	0.00019	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	9.33e-06	0.000189	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—TYMS—colon cancer	9.3e-06	0.000188	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—colon cancer	9.22e-06	0.000186	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—AKT1—colon cancer	9.11e-06	0.000184	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—colon cancer	9.11e-06	0.000184	CbGpPWpGaD
Diclofenac—ABCC1—Disease—BRAF—colon cancer	9.06e-06	0.000183	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PIK3CA—colon cancer	9e-06	0.000182	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—KRAS—colon cancer	8.9e-06	0.00018	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKT1—colon cancer	8.74e-06	0.000177	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.53e-06	0.000172	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MYC—colon cancer	8.48e-06	0.000171	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.47e-06	0.000171	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFB1—colon cancer	8.46e-06	0.000171	CbGpPWpGaD
Diclofenac—TTR—Disease—AKT1—colon cancer	8.4e-06	0.00017	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—colon cancer	8.3e-06	0.000168	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.2e-06	0.000166	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AKT1—colon cancer	8.18e-06	0.000165	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PIK3CA—colon cancer	8.18e-06	0.000165	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PPARG—colon cancer	8.08e-06	0.000163	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—colon cancer	8.04e-06	0.000162	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	8e-06	0.000162	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	7.88e-06	0.000159	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—colon cancer	7.84e-06	0.000158	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—colon cancer	7.82e-06	0.000158	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PPARG—colon cancer	7.79e-06	0.000157	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.77e-06	0.000157	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.68e-06	0.000155	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—colon cancer	7.56e-06	0.000153	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ABCB1—colon cancer	7.51e-06	0.000152	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.51e-06	0.000152	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.47e-06	0.000151	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TYMS—colon cancer	7.38e-06	0.000149	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—colon cancer	7.35e-06	0.000149	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—colon cancer	7.35e-06	0.000149	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—colon cancer	7.32e-06	0.000148	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CASP3—colon cancer	7.29e-06	0.000147	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ABCB1—colon cancer	7.22e-06	0.000146	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—colon cancer	7.2e-06	0.000146	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.16e-06	0.000145	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—colon cancer	7.09e-06	0.000143	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TYMS—colon cancer	7.09e-06	0.000143	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ABCB1—colon cancer	7.07e-06	0.000143	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FGFR3—colon cancer	7.04e-06	0.000142	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CTNNB1—colon cancer	7.02e-06	0.000142	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—colon cancer	6.97e-06	0.000141	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TYMS—colon cancer	6.95e-06	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CDKN1A—colon cancer	6.86e-06	0.000139	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—EP300—colon cancer	6.83e-06	0.000138	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.82e-06	0.000138	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.71e-06	0.000136	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—EP300—colon cancer	6.69e-06	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—colon cancer	6.68e-06	0.000135	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ABCB1—colon cancer	6.67e-06	0.000135	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—colon cancer	6.66e-06	0.000135	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.64e-06	0.000134	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SRC—colon cancer	6.64e-06	0.000134	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—colon cancer	6.59e-06	0.000133	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TYMS—colon cancer	6.55e-06	0.000132	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—colon cancer	6.55e-06	0.000132	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EP300—colon cancer	6.53e-06	0.000132	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—EP300—colon cancer	6.5e-06	0.000131	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—colon cancer	6.47e-06	0.000131	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—colon cancer	6.46e-06	0.000131	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1A—colon cancer	6.4e-06	0.000129	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—colon cancer	6.39e-06	0.000129	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—colon cancer	6.35e-06	0.000128	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SRC—colon cancer	6.35e-06	0.000128	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.25e-06	0.000126	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.21e-06	0.000126	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—colon cancer	6.18e-06	0.000125	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—colon cancer	6.13e-06	0.000124	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.12e-06	0.000124	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ABCB1—colon cancer	6.11e-06	0.000124	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—colon cancer	6.11e-06	0.000123	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EP300—colon cancer	6.09e-06	0.000123	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—colon cancer	6.08e-06	0.000123	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ABCB1—colon cancer	6.08e-06	0.000123	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TYMS—colon cancer	6e-06	0.000121	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—colon cancer	6e-06	0.000121	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TYMS—colon cancer	5.97e-06	0.000121	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—colon cancer	5.93e-06	0.00012	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SRC—colon cancer	5.92e-06	0.00012	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—colon cancer	5.88e-06	0.000119	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—colon cancer	5.69e-06	0.000115	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—colon cancer	5.69e-06	0.000115	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.68e-06	0.000115	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—colon cancer	5.68e-06	0.000115	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.58e-06	0.000113	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—colon cancer	5.56e-06	0.000112	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—colon cancer	5.5e-06	0.000111	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—colon cancer	5.46e-06	0.00011	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—colon cancer	5.36e-06	0.000108	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—colon cancer	5.3e-06	0.000107	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—colon cancer	5.29e-06	0.000107	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—EP300—colon cancer	5.29e-06	0.000107	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—colon cancer	5.26e-06	0.000106	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—colon cancer	5.23e-06	0.000106	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—colon cancer	5.23e-06	0.000106	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.23e-06	0.000106	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—colon cancer	5.19e-06	0.000105	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—colon cancer	5.18e-06	0.000105	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—EP300—colon cancer	5.1e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.09e-06	0.000103	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—colon cancer	5.05e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.04e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—colon cancer	5.02e-06	0.000102	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—colon cancer	4.98e-06	0.000101	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—colon cancer	4.95e-06	0.0001	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—colon cancer	4.92e-06	9.95e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—colon cancer	4.9e-06	9.9e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—colon cancer	4.89e-06	9.88e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—colon cancer	4.88e-06	9.87e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—colon cancer	4.83e-06	9.76e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—colon cancer	4.81e-06	9.72e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—colon cancer	4.67e-06	9.44e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—colon cancer	4.67e-06	9.44e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—colon cancer	4.64e-06	9.38e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.62e-06	9.34e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.6e-06	9.29e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—colon cancer	4.5e-06	9.1e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—colon cancer	4.47e-06	9.03e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—colon cancer	4.39e-06	8.88e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.35e-06	8.78e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—EP300—colon cancer	4.31e-06	8.71e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—colon cancer	4.29e-06	8.68e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—colon cancer	4.25e-06	8.6e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—colon cancer	4.25e-06	8.59e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—colon cancer	4.23e-06	8.55e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—colon cancer	4.18e-06	8.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—colon cancer	4.16e-06	8.42e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.13e-06	8.34e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—colon cancer	4.12e-06	8.34e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EP300—colon cancer	4.08e-06	8.25e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—colon cancer	4.04e-06	8.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SRC—colon cancer	3.97e-06	8.03e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—colon cancer	3.95e-06	7.99e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—colon cancer	3.95e-06	7.97e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—colon cancer	3.93e-06	7.94e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—colon cancer	3.91e-06	7.9e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—colon cancer	3.87e-06	7.82e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—colon cancer	3.82e-06	7.72e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—colon cancer	3.8e-06	7.67e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—colon cancer	3.77e-06	7.62e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.76e-06	7.6e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—colon cancer	3.71e-06	7.49e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—colon cancer	3.68e-06	7.43e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—colon cancer	3.65e-06	7.38e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—colon cancer	3.56e-06	7.19e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—colon cancer	3.55e-06	7.18e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—colon cancer	3.48e-06	7.04e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—colon cancer	3.46e-06	7e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—EP300—colon cancer	3.42e-06	6.91e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—colon cancer	3.35e-06	6.76e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—colon cancer	3.33e-06	6.72e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—colon cancer	3.29e-06	6.65e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—EP300—colon cancer	3.29e-06	6.64e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—colon cancer	3.28e-06	6.63e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—colon cancer	3.22e-06	6.51e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—EP300—colon cancer	3.22e-06	6.51e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.22e-06	6.5e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—colon cancer	3.19e-06	6.46e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—colon cancer	3.19e-06	6.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—colon cancer	3.08e-06	6.22e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—EP300—colon cancer	3.04e-06	6.14e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—colon cancer	3.02e-06	6.11e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—colon cancer	2.99e-06	6.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—colon cancer	2.96e-06	5.98e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—colon cancer	2.92e-06	5.89e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—colon cancer	2.8e-06	5.65e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—EP300—colon cancer	2.78e-06	5.62e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—EP300—colon cancer	2.77e-06	5.59e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—colon cancer	2.72e-06	5.5e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—colon cancer	2.6e-06	5.26e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—colon cancer	2.53e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—EP300—colon cancer	2.48e-06	5.02e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—colon cancer	2.47e-06	4.99e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—colon cancer	2.43e-06	4.91e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—EP300—colon cancer	2.42e-06	4.9e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—colon cancer	2.38e-06	4.81e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—colon cancer	2.33e-06	4.7e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—colon cancer	2.28e-06	4.61e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—EP300—colon cancer	2.27e-06	4.58e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—colon cancer	2.25e-06	4.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—colon cancer	2.07e-06	4.18e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—colon cancer	2.06e-06	4.16e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—colon cancer	2.05e-06	4.14e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—colon cancer	1.99e-06	4.02e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—colon cancer	1.95e-06	3.93e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—EP300—colon cancer	1.94e-06	3.91e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—colon cancer	1.84e-06	3.71e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—colon cancer	1.83e-06	3.71e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—colon cancer	1.8e-06	3.63e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—colon cancer	1.79e-06	3.63e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—colon cancer	1.68e-06	3.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—colon cancer	1.68e-06	3.39e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—colon cancer	1.67e-06	3.38e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—colon cancer	1.5e-06	3.03e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—EP300—colon cancer	1.49e-06	3.02e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—colon cancer	1.47e-06	2.96e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—colon cancer	1.43e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—colon cancer	1.37e-06	2.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—colon cancer	1.17e-06	2.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—colon cancer	1.11e-06	2.23e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—colon cancer	9.03e-07	1.82e-05	CbGpPWpGaD
